Immune reconstitution following rituximab-based immunochemotherapy in pediatric patients with B-cell non-Hodgkin lymphomas

Leuk Lymphoma. 2022 Jan;63(1):217-221. doi: 10.1080/10428194.2021.1998486. Epub 2021 Nov 2.

Authors

Alexandra Semchenkova¹, Vladimir Zhogov¹, Anastassia Rudneva¹, Liudmila Potapenko¹, Svetlana Plyasunova¹, Natalia Miakova¹, Elena Samochatova¹, Alexey Maschan¹, Alexander Popov¹

Affiliation

¹ Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.

PMID: 34727822
DOI: 10.1080/10428194.2021.1998486

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Child
Humans
Immune Reconstitution*
Immunotherapy
Lymphoma, B-Cell* / drug therapy
Rituximab / therapeutic use

Substances

Rituximab